BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21156751)

  • 1. TLR2 deficiency by compromising p19 (IL-23) expression limits Th 17 cell responses to Mycobacterium tuberculosis.
    Teixeira-Coelho M; Cruz A; Carmona J; Sousa C; Ramos-Pereira D; Saraiva AL; Veldhoen M; Pedrosa J; Castro AG; Saraiva M
    Int Immunol; 2011 Feb; 23(2):89-96. PubMed ID: 21156751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.
    Khader SA; Bell GK; Pearl JE; Fountain JJ; Rangel-Moreno J; Cilley GE; Shen F; Eaton SM; Gaffen SL; Swain SL; Locksley RM; Haynes L; Randall TD; Cooper AM
    Nat Immunol; 2007 Apr; 8(4):369-77. PubMed ID: 17351619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of TLR2-induced IL-12, reactive oxygen species, and inducible nitric oxide synthase expression by Mycobacterium tuberculosis antigens expressed inside macrophages during the course of infection.
    Gupta D; Sharma S; Singhal J; Satsangi AT; Antony C; Natarajan K
    J Immunol; 2010 May; 184(10):5444-55. PubMed ID: 20385877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.
    Drennan MB; Nicolle D; Quesniaux VJ; Jacobs M; Allie N; Mpagi J; Frémond C; Wagner H; Kirschning C; Ryffel B
    Am J Pathol; 2004 Jan; 164(1):49-57. PubMed ID: 14695318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23.
    Aliahmadi E; Gramlich R; Grützkau A; Hitzler M; Krüger M; Baumgrass R; Schreiner M; Wittig B; Wanner R; Peiser M
    Eur J Immunol; 2009 May; 39(5):1221-30. PubMed ID: 19350551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed induction of mycobacterial antigen-specific Th1-type CD4+ T cells in the lung after pulmonary mycobacterial infection.
    Yahagi A; Umemura M; Tamura T; Kariyone A; Begum MD; Kawakami K; Okamoto Y; Hamada S; Oshiro K; Kohama H; Arakawa T; Ohara N; Takatsu K; Matsuzaki G
    Int Immunol; 2010 Apr; 22(4):307-18. PubMed ID: 20167585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection.
    Demangel C; Palendira U; Feng CG; Heath AW; Bean AG; Britton WJ
    Infect Immun; 2001 Apr; 69(4):2456-61. PubMed ID: 11254607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
    Bafica A; Scanga CA; Feng CG; Leifer C; Cheever A; Sher A
    J Exp Med; 2005 Dec; 202(12):1715-24. PubMed ID: 16365150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
    Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
    Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of Toll-like receptor 2 on CD4(+) T cells facilitates local immune responses in patients with tuberculous pleurisy.
    Chen X; Zhang M; Zhu X; Deng Q; Liu H; Larmonier N; Graner MW; Zhou B
    J Infect Dis; 2009 Aug; 200(3):399-408. PubMed ID: 19552525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice.
    Yi Z; Fu Y; Yang C; Li J; Luo X; Chen Q; Zeng W; Jiang S; Jiang Y; He Y; Yang J; Liu Y; Li N; Zhu DY
    Vaccine; 2007 Jan; 25(4):638-48. PubMed ID: 17000035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular network of phosphatidylinositol 3-kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen-activated protein kinases pathways for regulating mycobacteria-induced IL-23 expression in human macrophages.
    Yang CS; Song CH; Lee JS; Jung SB; Oh JH; Park J; Kim HJ; Park JK; Paik TH; Jo EK
    Cell Microbiol; 2006 Jul; 8(7):1158-71. PubMed ID: 16819968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIGHT contributes to early but not late control of Mycobacterium tuberculosis infection.
    Musicki K; Briscoe H; Britton WJ; Saunders BM
    Int Immunol; 2010 May; 22(5):353-8. PubMed ID: 20185431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.
    Caruso AM; Serbina N; Klein E; Triebold K; Bloom BR; Flynn JL
    J Immunol; 1999 May; 162(9):5407-16. PubMed ID: 10228018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice.
    Kai H; Shibuya K; Wang Y; Kameta H; Kameyama T; Tahara-Hanaoka S; Miyamoto A; Honda S; Matsumoto I; Koyama A; Sumida T; Shibuya A
    Immunology; 2006 Jun; 118(2):233-9. PubMed ID: 16771858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells.
    Richardson ET; Shukla S; Sweet DR; Wearsch PA; Tsichlis PN; Boom WH; Harding CV
    Infect Immun; 2015 Jun; 83(6):2242-54. PubMed ID: 25776754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.